# The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure

> **NCT05940610** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University**

## Conditions studied

- Acute-On-Chronic Liver Failure
- Acute Liver Failure

## Interventions

- **BIOLOGICAL:** MSC-EVs

## Key facts

- **NCT ID:** NCT05940610
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The supply of msc-ev has been delayed and approval by the Ethics committee will take some time.
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05940610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05940610, "The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05940610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*